CBS 2019
CBSMD教育中心
中 文

肺动脉高压

Abstract

Recommended Article

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study Definition and Management of Segmental Pulmonary Hypertension ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial Survival prospects of treatment naïve patients with Eisenmenger: a systematic review of the literature and report of own experience Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification 中国肺动脉高压诊断与治疗指南(2021版) The right ventricle in pulmonary hypertension

Review Article2005 Feb;16(1):13-8.

JOURNAL:Coron Artery Dis. Article Link

The right ventricle in pulmonary hypertension

Chin KM, Kim NH, Rubin LJ. Keywords: pulmonary arterial hypertension; right ventricle function;

ABSTRACT

Pulmonary arterial hypertension (PAH) is a term used to classify a variety of conditions that share in common an injury to the pulmonary vasculature that produces elevations in pulmonary arterial pressure. However, it is the integrity of right ventricular function, rather than the degree of vascular injury, that is the major determinant of symptoms and survival in PAH. The article will review the normal structure and function of the right ventricle and summarize the impact of PAH and its treatments on right ventricular function.